Shin-Etsu Polymer (7970) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
23 Jul, 2026Executive summary
Net sales rose 9.3% year-over-year to ¥30,585 million for the quarter ended June 30, 2026, driven by strong demand in AI-related and automotive sectors.
Operating profit increased 8.6% year-over-year to ¥4,148 million, while ordinary profit grew 3.5% to ¥4,125 million.
Profit attributable to owners of parent declined 22.3% year-over-year to ¥2,415 million despite higher sales and operating profit.
Comprehensive income surged to ¥3,547 million, up 607.6% year-over-year, mainly due to foreign currency translation gains.
Financial highlights
Gross profit increased to ¥9,475 million from ¥8,769 million year-over-year.
Basic earnings per share for the quarter were ¥30.05, down from ¥38.65 a year earlier.
Equity ratio improved to 84.9% from 84.4% at the previous fiscal year-end.
Total assets stood at ¥153,372 million, up ¥368 million from March 31, 2026.
Outlook and guidance
Full-year forecast for FY ending March 31, 2027: net sales ¥120,000 million (+4.2% YoY), operating profit ¥16,000 million (+14.0% YoY), ordinary profit ¥16,000 million (+14.2% YoY), profit attributable to owners of parent ¥10,500 million (+6.1% YoY).
Annual dividend forecast raised to ¥66 per share, up ¥4 from the previous year.
Latest events from Shin-Etsu Polymer
- Advanced resin technologies and global reach drive growth in automotive, semiconductor, and medical markets.7970
Corporate presentation14 Jul 2026 - Profits and sales rose on robust AI-related semiconductor and automotive demand, but FY2027 outlook is uncertain.7970
Q4 202622 May 2026 - Precision molding and advanced materials drive global growth, led by innovation and sustainability.7970
Corporate presentation20 Mar 2026 - Operating profit rose 5.7% despite lower sales, with full-year guidance and dividends increased.7970
Q1 202520 Mar 2026 - Operating profit rose 17.7% on strong Precision Molding and semiconductor market recovery.7970
Q2 202520 Mar 2026 - Strong profit growth and robust segment performance support an optimistic full-year outlook.7970
Q3 202520 Mar 2026 - Operating profit rose 20.1% year-over-year, led by semiconductors; FY2026 outlook withheld.7970
Q4 202520 Mar 2026 - Strong profit growth and higher dividend forecast, led by semiconductor and medical demand.7970
Q1 202620 Mar 2026 - Profits rose on semiconductor strength, but comprehensive income fell on currency losses.7970
Q2 202620 Mar 2026